SCHEMBL13428196

SCHEMBL13428196

Cc1ccc(-c2c3cc(N4c5ccccc5CCc5ccccc54)ccc3c(-c3cccc4ccccc34)c3cc(N4c5ccccc5CCc5ccccc54)ccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
KDM4E B2RXH2 4/20 0.36
LMNA P02545 4/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 3/20 0.36
FLT3 P36888 1/20 0.35
POLB P06746 2/20 0.34
MEN1 O00255 2/20 0.33
GAA P10253 2/20 0.33
TLR9 Q9NR96 1/20 0.33
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 5/20 0.32
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
CYP11B1 P15538 2/20 0.32
CYP11B2 P19099 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428194 0.94 POLB (0.34) MAPTKDM4ELMNAKMT2AHTT
SCHEMBL13427065 0.94 KMT2A (0.35) MAPTKDM4ELMNAKMT2AHTT
SCHEMBL13428185 0.92 HDAC8 (0.35) KDM4ELMNAHTTPOLBALDH1A1
SCHEMBL13428173 0.91 PDE6D (0.38) MAPTKDM4ELMNAHTTPOLB
SCHEMBL13008826 0.91 PDE6D (0.34) MAPTKDM4ELMNAHTTPOLB
SCHEMBL13008867 0.91 PDE6D (0.34) MAPTKDM4ELMNAHTTPOLB
SCHEMBL13008454 0.90 NPSR1 (0.38) MAPTKDM4ELMNAKMT2AHTT
SCHEMBL13428125 0.90 HDAC8 (0.36) KDM4ELMNAHTTPOLBALDH1A1
SCHEMBL13009166 0.90 POLB (0.38) MAPTKDM4ELMNAHTTPOLB
SCHEMBL13008448 0.89 GPR84 (0.34) KDM4ELMNAKMT2AHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A MAPT 3713/4885KDM4E 4138/4885LMNA 4186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.